michigan semaglutide stomach paralysis lawyer intestinal law office Ozempic® & Semaglutide glp-1 gastroparesis law firm in

Immune system disorders: hypersensitivity Nervous system disorders: stroke/cerebrovascular accident Vascular disorders: arterial events (including arterial thromboembolism and myocardial infarction), aggravation of varicose veins Skin and subcutaneous tissue disorders: urticaria, chloasma Reproductive system and breast disorders: penile disorders, including local reactions on penis (in male partners of women using NuvaRing), galactorrhea Consult the labeling of all concurrently-used drugs to obtain further information about interactions with hormonal contraceptives or the potential for enzyme alterations

### AOD-9604 Mechanism of Action AOD-9604 is believed to promote **fat loss** through: - Stimulation of lipolysis in adipose tissue via beta-3 adrenergic receptor pathways - Inhibition of lipogenesis (new fat formation) - No effect on growth hormone receptors (does not promote tissue growth) - No effect on IGF-1 levels or blood glucose Importantly, AOD-9604 does **not** suppress appetite or affect food intake it is purely a lipolytic **fat loss peptide**

Zepbound (tirzepatide): Injection for weight loss

During an extension period with treatment for up to 52 weeks, insulin could be adjusted to achieve defined glucose target levels